Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy Stock

Showing results (271-280 of 283) with videos related to

Pageof 29
Sort By:
American Journal of Hematology|July 3, 2026
Signaling Mutations Negate the Favorable Impact of NPM1 Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With VEN/HMAFieke W Hoff, Joshua F Zeidner, Geeta Torlapati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2024
Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALLGregory W Roloff, Ibrahim Aldoss, Noam E Kopmar, et al.
Cancer Discovery|June 9, 2021
Enhancer Hijacking Drives Oncogenic <i>BCL11B</i> Expression in Lineage-Ambiguous Stem Cell LeukemiaLindsey E Montefiori, Sonja Bendig, Zhaohui Gu, et al.
Nature Communications|November 9, 2016
Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemiaZhaohui Gu, Michelle Churchman, Kathryn Roberts, et al.
Blood Advances|August 2, 2024
Impact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALLIbrahim Aldoss, Gregory W Roloff, Rawan Faramand, et al.
Nature Genetics|January 16, 2019
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemiaZhaohui Gu, Michelle L Churchman, Kathryn G Roberts, et al.
Bone Marrow Transplantation|August 23, 2025
The impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemiaTimothy E O'Connor, Chenyu Lin, Gregory W Roloff, et al.
Nature Genetics|October 4, 2024
Multiomic profiling identifies predictors of survival in African American patients with acute myeloid leukemiaAndrew Stiff, Maarten Fornerod, Bailee N Kain, et al.
Nature Genetics|January 22, 2013
The genomic landscape of hypodiploid acute lymphoblastic leukemiaLinda Holmfeldt, Lei Wei, Ernesto Diaz-Flores, et al.
Nature Genetics|November 8, 2016
Deregulation of DUX4 and ERG in acute lymphoblastic leukemiaJinghui Zhang, Kelly McCastlain, Hiroki Yoshihara, et al.
Pageof 29

Showing results (271-280 of 283) with videos related to

Sort By:
Pageof 29
American Journal of Hematology|July 3, 2026
Signaling Mutations Negate the Favorable Impact of NPM1 Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With VEN/HMAFieke W Hoff, Joshua F Zeidner, Geeta Torlapati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2024
Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALLGregory W Roloff, Ibrahim Aldoss, Noam E Kopmar, et al.
Cancer Discovery|June 9, 2021
Enhancer Hijacking Drives Oncogenic <i>BCL11B</i> Expression in Lineage-Ambiguous Stem Cell LeukemiaLindsey E Montefiori, Sonja Bendig, Zhaohui Gu, et al.
Nature Communications|November 9, 2016
Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemiaZhaohui Gu, Michelle Churchman, Kathryn Roberts, et al.
Blood Advances|August 2, 2024
Impact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALLIbrahim Aldoss, Gregory W Roloff, Rawan Faramand, et al.
Nature Genetics|January 16, 2019
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemiaZhaohui Gu, Michelle L Churchman, Kathryn G Roberts, et al.
Bone Marrow Transplantation|August 23, 2025
The impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemiaTimothy E O'Connor, Chenyu Lin, Gregory W Roloff, et al.
Nature Genetics|October 4, 2024
Multiomic profiling identifies predictors of survival in African American patients with acute myeloid leukemiaAndrew Stiff, Maarten Fornerod, Bailee N Kain, et al.
Nature Genetics|January 22, 2013
The genomic landscape of hypodiploid acute lymphoblastic leukemiaLinda Holmfeldt, Lei Wei, Ernesto Diaz-Flores, et al.
Nature Genetics|November 8, 2016
Deregulation of DUX4 and ERG in acute lymphoblastic leukemiaJinghui Zhang, Kelly McCastlain, Hiroki Yoshihara, et al.
Pageof 29